肺炎支原体肺炎治疗新进展

Progress on the treatment of mycoplasma pneumoniae pneumonia

肺炎支原体是儿童社区获得性肺炎的常见病原。近年来肺炎支原体肺炎（mycoplasma pneumoniae pneumonia，MPP）的发病率逐年增高，国内外关于难治性MPP的病例报道也明显增多，MPP的治疗成为临床医师关注的热点。本文就MPP的抗生素治疗、免疫治疗及其他辅助治疗进展作一综述。

Mycoplasma pneumoniae is the common pathogen of community-acquired pneumonia in children. In recent years, the incidence of mycoplasma pneumoniae pneumonia （MPP） has increased year by year. And it is found that case reports about intractable MPP at home and abroad have also significantly increased. The treatments of MPP become the focus in clinical physicians. This paper summarized about progress of MPP in antibiotic therapy,immune therapy and other ancillary treatment.